As of 2026-09-22, the Relative Valuation of EyePoint Pharmaceuticals Inc (EYPT) is (37.99) USD. This relative valuation is based on P/E multiples. With the latest stock price at 4.02 USD, the upside of EyePoint Pharmaceuticals Inc based on Relative Valuation is -1045.1%.
The range of the Relative Valuation is (24.37) - (52.41) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 8.2x - 20.6x | 12.6x |
| Forward P/E multiples | 8.3x - 17.8x | 13.2x |
| Fair Price | (24.37) - (52.41) | (37.99) |
| Upside | -706.3% - -1403.7% | -1045.1% |
| Date | P/E |
| 2026-09-18 | -1.30 |
| 2026-09-17 | -1.35 |
| 2026-09-16 | -1.17 |
| 2026-09-15 | -1.24 |
| 2026-09-14 | -1.44 |
| 2026-09-11 | -1.43 |
| 2026-09-10 | -1.44 |
| 2026-09-09 | -1.47 |
| 2026-09-08 | -1.55 |
| 2026-09-04 | -1.55 |
| 2026-09-03 | -1.55 |
| 2026-09-02 | -1.62 |
| 2026-09-01 | -1.55 |
| 2026-08-31 | -1.52 |
| 2026-08-28 | -1.52 |
| 2026-08-27 | -1.57 |
| 2026-08-26 | -1.69 |
| 2026-08-25 | -1.70 |
| 2026-08-24 | -1.65 |
| 2026-08-21 | -1.80 |
| 2026-08-20 | -1.83 |
| 2026-08-19 | -2.13 |
| 2026-08-18 | -1.85 |
| 2026-08-17 | -1.65 |
| 2026-08-14 | -5.00 |
| 2026-08-13 | -4.57 |
| 2026-08-12 | -4.59 |
| 2026-08-11 | -4.42 |
| 2026-08-10 | -4.43 |
| 2026-08-07 | -4.71 |
| 2026-08-06 | -4.35 |
| 2026-08-05 | -4.15 |
| 2026-08-04 | -3.95 |
| 2026-08-03 | -4.21 |
| 2026-07-31 | -4.15 |
| 2026-07-30 | -4.36 |
| 2026-07-29 | -4.04 |
| 2026-07-28 | -4.05 |
| 2026-07-27 | -4.21 |
| 2026-07-24 | -4.13 |
| 2026-07-23 | -4.23 |
| 2026-07-22 | -4.29 |
| 2026-07-21 | -4.42 |
| 2026-07-20 | -4.29 |
| 2026-07-17 | -4.51 |
| 2026-07-16 | -4.42 |
| 2026-07-15 | -4.69 |
| 2026-07-14 | -4.65 |
| 2026-07-13 | -4.84 |
| 2026-07-10 | -4.99 |